Mikati, Abdul Ghani
Mandelbaum, Max
Sapnar, Shweta
Puri, Ajit S.
Silver, Brian
Goddeau, Richard P. Jr
Haussen, Diogo C.
Moonis, Majaz
Jun-O’Connell, Adalia H.
Henninger, Nils http://orcid.org/0000-0002-3883-5623
Funding for this research was provided by:
National Institute of Neurological Disorders and Stroke (K08NS091499)
Article History
Received: 5 October 2018
Revised: 22 January 2019
Accepted: 27 March 2019
First Online: 12 April 2019
Compliance with Ethical Standards
:
: Dr. Henninger serves on the advisory board of Omniox, Inc. and serves as consultant to Astrocyte Pharmaceuticals, Inc. Dr. Silver receives compensation as a surveyor for the Joint Commission, for review of medicolegal malpractice cases, and for adjudication of stroke outcomes in the Women’s Health Initiative. Dr. Puri is a consultant for Stryker Neurovascular, Scientica Vascular, Cerenovus, receives research support from Stryker Neurovascular and Medtronic Neurovascular, and reports stock options in InNeuroCo. Dr. Haussen is a consultant for Stryker Neurovascular and Vesalio. All other authors declare no competing interests.
: This study was reviewed and approved by our Institutional Review Board and procedures followed were in accordance with institutional guidelines and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Health Insurance Portability and Accountability Act (HIPAA) waiver of authorization was granted. We adhere to the STrengthening the Reporting of OBservational studies in Epidemiology (STROBE) guidelines (ExternalRef removed).